Empiric Therapy After a First Kidney Stone
The guideline-correct next step is a 24-hour urine collection he may never actually complete — and starting nothing while waiting for it is not a neutral choice.
Jamal H., a 29-year-old man, works two jobs — a warehouse shift most weekdays and weekend deliveries for a courier app — and lives forty minutes outside the city where his stone clinic is located, without reliable access to a car on weekdays. His first kidney stone passed spontaneously a week ago after two days of colicky left flank pain; the stone itself was recovered and sent for analysis, confirmed as calcium oxalate — which narrows the question without answering it, since calcium oxalate is the shared endpoint of hypercalciuria, hyperoxaluria and hypocitraturia alike, and the three call for different drugs. He has no other medical problems, drinks minimal water during his warehouse shifts because breaks are tightly scheduled, and eats mostly on the go between jobs. Today's visit is his only scheduled follow-up before he goes back to a full work week that leaves him little room for another appointment, let alone a multi-day urine collection that has to be refrigerated and dropped off during business hours.
The guideline-recommended next step for a first-time stone former who is motivated and interested — which Jamal genuinely is — is a 24-hour urine collection to identify the specific metabolic abnormality driving his stone risk, so that any pharmacologic therapy actually targets the right mechanism. In practice, that guideline-correct step is completed by a small minority of eligible patients: population-level data put completion of a 24-hour collection within six months of a symptomatic stone event below 10%, driven largely by exactly the access barriers Jamal is describing out loud — a schedule that doesn't accommodate a multi-day collection and a commute that makes dropping off a sample logistically difficult. Goldfarb, in making the published case for empiric therapy in stone disease, puts it directly: for many first-time formers, general dietary and fluid measures plus a reasonable default therapy capture much of the achievable benefit, and treating the 24-hour collection as a gate before any intervention risks a patient who is genuinely willing to do something leaving with nothing.
In clinic, one week after his first stone
I'd rather know what we're actually treating before we treat it. If his real driver is hyperuricosuria or hypocitraturia and we start empiric citrate blind, we might do nothing useful; if it's hyperoxaluria and we start a drug aimed at calcium excretion, we could genuinely make the wrong parameter worse. Get the 24-hour collection first.
In principle I agree that's the right order. In practice, fewer than one patient in ten completes a 24-hour collection in the six months after a symptomatic stone, and Jamal is telling us directly why — two jobs, a commute, no easy way to refrigerate and drop off a sample on a weekday. If we make the collection a precondition for any therapy, the realistic outcome for a lot of patients like him is no therapy at all, not eventually-correct therapy.
A guideline-correct plan that mostly doesn't happen in practice isn't actually the safer default just because it's the more precise one on paper.
I don't think we have to choose between those two positions as if they're the only options. Fluid intake, sodium moderation, and moderating animal protein carry essentially no risk regardless of what his eventual urine chemistry shows — there's no version of his metabolic pattern where those measures make things worse. Start those today, keep pushing to schedule the collection around his actual availability, and hold any composition-specific drug decision until the results are in.
Agreed: start fluid and dietary counseling today regardless of results, and schedule the 24-hour urine collection around a day off he can actually plan for, with a home refrigeration and drop-off plan worked out before he leaves.
Not fully agreed: the urologist would have started an empiric citrate trial today as well rather than wait on the collection at all, given how often the test goes uncompleted; the nephrologist held firm that composition-specific therapy should wait for the actual numbers.